Constitutive activation of STATs upon in vivo human immunodeficiency virus infection

Blood

Volumn 94, Issue 12, 1999, Pages 4202-4209

  Bovolenta, Chiara ^a   Camorali, Laura ^b   Lorini, Alessandro L ^b   Ghezzi, Silvia ^b   Vicenzi, Elisa ^b   Lazzarin, Adriano ^b   Poli, Guido ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INTERFERON; STAT1 PROTEIN; STAT5 PROTEIN;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

EID: 0032805660     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4202     Document Type: Article

References (44)

1. Cohen OJ, Kinter A, Fauci AS: Host factors in the pathogenesis of HIV disease. Immunol Rev 159:31, 1997
2. Roederer M, De Rosa SC, Watanabe N, Herzenberg LA: Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. Semin Immunol 9:389, 1997
3. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251, 1995
4. Leonard WJ, O'Shea JJ: Jaks and STATs: biological implications. Annu Rev Immunol 16:293, 1998
5. Darnell JE Jr: STATs and gene regulation. Science 277:1630, 1997
6. Vicenzi E, Biswas P, Mengozzi M, Poli G: Role of proinflammatory cytokines and β-chemokines in controlling HIV replication. J Leukoc Biol 62:34, 1997
7. Bovolenta C, Lorini AL, Mantelli B, Camorali L, Novelli F, Poli G: A selective defect of IFN-γ- but not of IFN-α-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-γ against HIV-1. J Immunol 162:323, 1999
8. Bovolenta C, Camorali L, Lorini AL, Poli G: HIV infection and signal transduction. J Biol Regul Homeost Agents 12:63, 1998
9. Shrikant P, Benos DJ, Tang LP, Benveniste EN: HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 156:1307, 1996
10. Selliah N, Finkel TH: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness. J Immunol 160:5697, 1998
11. Pericle F, Pinto LA, Hicks S, Kirken RA, Sconocchia G, Rusnak J, Dolan MJ, Shearer GM, Segal DM: HIV-1 infection induces a selective reduction in STAT5 protein expression. J Immunol 160:28, 1998
12. Vicenzi E, Bagnarelli P, Santagostino E, Ghezzi S, Alfano M, Sinnone MS, Fabio G, Turchetto L, Moretti G, Lazzarin A, Mantovani A, Mannucci PM, Clementi M, Gringeri A, Poli G: Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 89:191, 1997
13. Berger EA, Doms RW, Fenyo EM, Korber BT, Littman DR, Moore JP, Sattentau QJ, Schuitemaker H, Sodroski J, Weiss RA: A new classification for HIV-1. Nature 391:240, 1998
14. Franzoso G, Biswas P, Poli G, Carlson LM, Brown KD, Tomita-Yamaguchi M, Fauci AS, Siebenlist UK: A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells. J Exp Med 180:1445, 1994
15. Hill CM, Deng H, Unutmaz D, Kewalramani VN, Bastiani L, Gorny MK, Zolla-Pazner S, Littman DR: Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J Virol 71:6296, 1997
16. Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L: Cloning and expression of STAT5 and an additional homologue (STAT5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci USA 92:8831, 1995
17. Wakao H, Gouilleux F, Groner B: Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13:2182, 1994
18. Bovolenta C, Gasperini S, McDonald PP, Cassatella MA: High affinity receptor for IgG (Fc gamma RI/CD64) gene and STAT protein binding to the IFN-gamma response region (GRR) are regulated differentially in human neutrophils and monocytes by IL-10. J Immunol 160:911, 1998
19. Flanagan JR, Becker KG, Ennist DL, Gleason SL, Driggers PH, Levi BZ, Appella E, Ozato K: Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol 12:38, 1992
20. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305, 1989
21. Taniguchi T, Minami Y: The IL-2/IL-2 receptor system: A current overview. Cell 73:5, 1993
22. Leonard WJ, Noguchi M, Russell SM, McBride OW: The molecular basis of X-linked severe combined immunodeficiency: The role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. Immunol Rev 138:61, 1994
23. Boehm U, Klamp T, Groot M, Howard JC: Cellular response to inteferon-γ. Annu Rev Immunol 15:749, 1997
24. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, Burny A, Gallo RC: Interferon alpha and Tat involvement in the immunosuppression of uninlected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA 95:3851, 1998
25. Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA: Activation of J AK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 13:5605, 1994
26. Yu CR, Lin JX, Fink DW, Akira S, Bloom ET, Yamauchi A: Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J Immunol 157:126, 1996
27. Meinke A, Barahmand-Pour F, Wohrl S, Stoiber D, Decker T: Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol 16:6937, 1996
28. Fasler-Kan E, Pansky A, Wiederkehr M, Battegay M, Heim MH: Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells. Eur J Biochem 254:514, 1998
29. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H: Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J AIDS 2:158, 1989
30. Rinaldo CR, Armstron JA, Kingsley LA, Zhou S, Ho M: Relation of alpha and gamma interferon levels to development of AIDS in homosexual men. J Exp Pathol 5:127, 1990
31. Emilie D, Peuchmaur M, Maillot MC, Crevon MC, Brousse N, Delfraissy JF, Dormont J, Galanaud P: Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 86:148, 1990
32. Ghezzi S, Vicenzi E, Soldini L, Tambussi G, Murone M, Lazzarin A, Poli G: Experiences in immune reconstitution. The rationale for intereleukin-2 administration to HIV-infected individuals. J Biol Regul Homo Agents 11:74, 1997
33. Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, Macher AM, Djeu JY, Manischewitz JF, Jackson L, Fauci AS, Quinnan GV Jr: Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 72:398, 1983
34. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS: Qualitative anlysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective detect in soluble antigen recognition. N Engl J Med 313:79, 1983
35. Ciardi M, Sharief MK, Noori MA, Thompson EJ, Salotti A, Rossi F, Vullo V, Catania S, Sorice F, Cirelli A: Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies. J Neurol Sci 115:117, 1993
36. Friedman MC, Migone TS, Russell SM, Leonard WJ: Different interleukin 2 receptor beta-chain tyrosine couple to at least two signaling pathways and synergistically mediate interleukin-2-induced proliferation. Proc Natl Acad Sci USA 93:2077, 1996
37. Goldsmith MA, Lai SY, Xu W, Amaral MC, Luczek ES, Parent LJ, Mills GB, Tarr V, Longmore GD, Greene WC: Growth signal transdtiction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain. J Biol Chem 270:729, 1995
38. Miyazaki T, Takaoka A, Nogueira L, Dikic I, Fujii H, Tsujino S, Mitani Y, Maeda M, Schlessinger J, Taniguchi T: Pyk2 is a downstream mediator of the IL-2 receptor-coupled JAK signaling pathway. Genes Dev 12:770, 1998
39. Amadori A, De Silvestro G, Zamarchi R, Veronese ML, Mazza MR, Schiavo G, Panozzo M, De Rossi A, Ometto L, Mous J, Barelli A, Borri A, Salmaso L, Chieco-Bianchi L: CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. J Immunol 148:2709, 1992
40. Lokuta MA, McDowell MA, Paulnock DM: Identification of an additional isotbrm of STAT5 expressed in immature macrophages. J Immunol 161:1594, 1998
41. Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A: Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. EMBO J 15:2425, 1996
42. Azam M, Lee C, Strehlow I, Schindler C: Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 6:691, 1997
43. Meyer J, Jucker M, Ostertag W, Stocking C: Carboxyl-truncated STAT5 beta is generated by a nucleus-associated serine protease in early hematopoietic progenitors. Blood 91:1901, 1998
44. Bovolenta C, Testolin L, Benussi L, Lievens PM, Liboi E: Positive selection of apoptosis-resistant cells correlates with activation of dominant-negative STAT5. J Biol Chem 273:20779, 1998